Page last updated: 2024-08-21

azomycin and Ventilator-Associated Pneumonia

azomycin has been researched along with Ventilator-Associated Pneumonia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Nambiar, S; Schumann, K; Walinsky, S	1

Other Studies

1 other study(ies) available for azomycin and Ventilator-Associated Pneumonia

Article	Year
FDA's Limited Population Pathway for Antibacterial and Antifungal Drugs. Clinical pharmacology and therapeutics, 2021, Volume: 109, Issue:4 Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Cross Infection; Drug Approval; Drug Resistance, Microbial; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Humans; Liposomes; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Nitroimidazoles; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Sisomicin; United States; United States Food and Drug Administration	2021

Article

Year

FDA's Limited Population Pathway for Antibacterial and Antifungal Drugs.

Clinical pharmacology and therapeutics, 2021, Volume: 109, Issue:4

Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Cross Infection; Drug Approval; Drug Resistance, Microbial; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Humans; Liposomes; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Nitroimidazoles; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Sisomicin; United States; United States Food and Drug Administration

2021